Article info

Original research
FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III

Authors

  • Minlin Jiang Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Chunyan Wu Department of Pathology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Liping Zhang Department of Pathology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Chenglong Sun Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Hao Wang Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Yi Xu Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Hui Sun Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Jun Zhu Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Wencheng Zhao Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Qiyu Fang Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Jia Yu Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Peixin Chen Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Shengyu Wu Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Zixuan Zheng Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, ChinaTongji University, No 1239 Siping Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Yayi He Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  • Caicun Zhou Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine, No 507 Zhengmin Road, Shanghai 200433, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Caicun Zhou; caicunzhoudr{at}126.com; Dr Yayi He; 2250601{at}qq.com
View Full Text

Citation

Jiang M, Wu C, Zhang L, et al
FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III

Publication history

  • Accepted April 20, 2021
  • First published May 18, 2021.
Online issue publication 
February 07, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.